ArticleJournal of microbiology and biotechnology2026
Beneficial Effects of
Article in Journal of microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Increased ultraviolet (UV) exposure due to ozone depletion significantly affects human skin health. Recent skin research has been exploring various interventions to counteract the effects of UV-induced photoaging. UV directly affects skin components such as collagen and natural moisturizing factors (NMF), which are essential for the skin's structural integrity and hydration. Recent studies on the gut-skin axis have shown that certain probiotic strains could significantly improve skin aging. So, we examined the effect of ABF21013 on pro-collagen production and hyaluronic acid secretion using skin tissue from UVB-induced mice treated with ABF21013. Our findings reveal that ABF21013 reduced the total number of wrinkles and skin thickness by up-regulating MMP degradation and pro-collagen biosynthesis. These results indicate that ABF21013 can regulate wrinkle formation through the enhancement of collagen. Additionally, we observed downregulated transepidermal water loss (TEWL) regarding skin moisturizing. We also detected increased expression of EGFR ligands, AMPKα, hyaluronan synthase (HAS) -1/-2, and filaggrin. We have proved that ABF21013 can protect the skin barrier by activating the EGFR signaling pathway. Taken together, these results demonstrated that
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.